Clinical Trials Directory

Trials / Completed

CompletedNCT04792736

Prognostic Value of Lactates in ICU

Prognostic Value of Lactates in Predicting Intensive Care Unit Mortality

Status
Completed
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Mongi Slim Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.

Detailed description

In this study, conducted over o 12 months period, arterial blood lactates levels were measured in ICU patients at admission (H0), every 6 hours during the first day and and H48. This trial included traumatic, medical and surgical patients requiring ICU stay for a predictive period \> to 24 hours. Blood lactates were evaluated as a prognostic parameter in predicting ICU mortality and compared to classic prognostic scores such as: SOFA score, IGS II and APACHE II. The primary end point was ICU mortality.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood lactate levelBlood lactate level measured at admission H0, every 6 hours during the first 24 h and at H48

Timeline

Start date
2019-06-01
Primary completion
2020-06-30
Completion
2020-07-31
First posted
2021-03-11
Last updated
2021-03-11

Locations

2 sites across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT04792736. Inclusion in this directory is not an endorsement.